Day One Biopharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DAY ONE BIOPHARMS
DAY ONE BIOPHARMS has two approved drugs.
There are two US patents protecting DAY ONE BIOPHARMS drugs.
There are forty-nine patent family members on DAY ONE BIOPHARMS drugs in twenty-seven countries.
Summary for Day One Biopharms
| International Patents: | 49 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Day One Biopharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharms | OJEMDA | tovorafenib | FOR SUSPENSION;ORAL | 218033-001 | Apr 23, 2024 | RX | Yes | Yes | 10,426,782 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Day One Biopharms | OJEMDA | tovorafenib | TABLET;ORAL | 217700-001 | Apr 23, 2024 | RX | Yes | Yes | 10,426,782 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Day One Biopharms | OJEMDA | tovorafenib | FOR SUSPENSION;ORAL | 218033-001 | Apr 23, 2024 | RX | Yes | Yes | 8,293,752 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Day One Biopharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 104370828 | ⤷ Start Trial |
| Spain | 2635729 | ⤷ Start Trial |
| China | 106456787 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
